420 Natural: Successful own brand launched
Green Leaf

Market launch


Successful market launch of own brand 420 NATURAL

Paderborn (ots)

Four 20 Pharma GmbH, manufacturer, wholesaler and importer of medical cannabis, has been present on the medical cannabis market since the end of September with the launch of its own non-irradiated cannabis brand 420 NATURAL. To ensure continuous patient supply, Four 20 Pharma GmbH has signed a long-term and exclusive supply agreement with its partner NGC.

"The quality of our product speaks for itself - gently dried, hand-picked and non-irradiated. The launch was a complete success. After the first week, we already increased our production staff to meet the demand," explains Thomas Schatton, CEO of Four 20 Pharma GmbH. "Patient well-being and product quality are our top priorities. Therefore, in addition to our wholesale license, we also have a manufacturer's license and package the goods in the usual pharmacy supply quantity in our GMP-certified facility. This is the only way we can guarantee full control of the final product."

Lisa McCormack, President and CEO of Northern Green Canada is also very positive. "We are excited about the development of our business relationship. It is extremely satisfying to work with a partner who is as committed as we are to patient care and the delivery of the highest quality medical cannabis."

Four 20 Pharma GmbH will expand its existing strain portfolio in the coming weeks. In addition to the Original Glue strain, the Paderborn-based company will also offer the indica strain Shishkaberry. The company currently expects to add the first sativa variety to its portfolio in the first quarter of 2021.

About Four 20 Pharma GmbH

Four 20 Pharma GmbH is GDP and GMP certified as a manufacturer, wholesaler and importer of medical cannabis as well as medical devices. The company, based in Paderborn, Germany, was founded in 2018 and holds a narcotics license in accordance with Section 3 of the German Narcotics Act (BtMG) and a pharmaceutical wholesale license in accordance with Section 52a of the German Medicines Act (AMG) for the whole of Europe. In addition, the medical cannabis specialist holds the necessary import licenses for the importation of medical cannabis into Germany, a manufacturing permit, and the necessary, product-specific permit in accordance with § 7 AMG and § 1 AMRadV for the marketing of medicinal products. Four 20 Pharma GmbH is involved as a Gold Sponsor with the Association for Cannabis as Medicine (ACM) and as a Platinum Sponsor with the International Association for Cannabinoid Medicines (IACM).

The company is a reliable partner for physicians, pharmacies, medical institutions and patients in the field of medical cannabis. For more information, please visit our website at www.420pharma.de.

About Northern Green Canada Inc.

Northern Green Canada Inc. is a federally licensed, EU GMP certified medical cannabis manufacturer focused on providing cannabis medicines for a better quality of life. NGC is a research and development driven company committed to patient health and wellness. The experienced team of experts operates in an indoor cultivation and processing facility with an area of 2500 sqm2 and an expansion capacity of 4275 sqm2. The company is expanding its extraction capacity to produce oils and is working with respected partners on treatment-based cannabis medicines. For more information, please visit our website at www.northerngreencanada.com.


Email: mmill@northerngreencanada.com

Press contact:

Four 20 Pharma Ltd.
+49 52 51 / 390 32 10

Original-Content of: Four 20 Pharma GmbH, transmitted by news aktuell

Sticky Phone icon